Literature DB >> 18332104

DEK is a poly(ADP-ribose) acceptor in apoptosis and mediates resistance to genotoxic stress.

F Kappes1, J Fahrer, M S Khodadoust, A Tabbert, C Strasser, N Mor-Vaknin, M Moreno-Villanueva, A Bürkle, D M Markovitz, E Ferrando-May.   

Abstract

DEK is a nuclear phosphoprotein implicated in oncogenesis and autoimmunity and a major component of metazoan chromatin. The intracellular cues that control the binding of DEK to DNA and its pleiotropic functions in DNA- and RNA-dependent processes have remained mainly elusive so far. Our recent finding that the phosphorylation status of DEK is altered during death receptor-mediated apoptosis suggested a potential involvement of DEK in stress signaling. In this study, we show that in cells committed to die, a portion of the cellular DEK pool is extensively posttranslationally modified by phosphorylation and poly(ADP-ribosyl)ation. Through interference with DEK expression, we further show that DEK promotes the repair of DNA lesions and protects cells from genotoxic agents that typically trigger poly(ADP-ribose) polymerase activation. The posttranslational modification of DEK during apoptosis is accompanied by the removal of the protein from chromatin and its release into the extracellular space. Released modified DEK is recognized by autoantibodies present in the synovial fluids of patients affected by juvenile rheumatoid arthritis/juvenile idiopathic arthritis. These findings point to a crucial role of poly(ADP-ribosyl)ation in shaping DEK's autoantigenic properties and in its function as a promoter of cell survival.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18332104      PMCID: PMC2423161          DOI: 10.1128/MCB.01921-07

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  65 in total

1.  The protein encoded by the proto-oncogene DEK changes the topology of chromatin and reduces the efficiency of DNA replication in a chromatin-specific manner.

Authors:  V Alexiadis; T Waldmann; J Andersen; M Mann; R Knippers; C Gruss
Journal:  Genes Dev       Date:  2000-06-01       Impact factor: 11.361

2.  Autoantibodies to DEK oncoprotein in human inflammatory disease.

Authors:  X Dong; J Wang; F N Kabir; M Shaw; A M Reed; L Stein; L E Andrade; V F Trevisani; M L Miller; T Fujii; M Akizuki; L M Pachman; M Satoh; W H Reeves
Journal:  Arthritis Rheum       Date:  2000-01

3.  Identification of differentially expressed genes in human melanoma cells with acquired resistance to various antineoplastic drugs.

Authors:  C Grottke; K Mantwill; M Dietel; D Schadendorf; H Lage
Journal:  Int J Cancer       Date:  2000-11-15       Impact factor: 7.396

Review 4.  CD95's deadly mission in the immune system.

Authors:  P H Krammer
Journal:  Nature       Date:  2000-10-12       Impact factor: 49.962

5.  The identification of novel therapeutic targets for the treatment of malignant brain tumors.

Authors:  R A Kroes; A Jastrow; M G McLone; H Yamamoto; P Colley; D S Kersey; V W Yong; E Mkrdichian; L Cerullo; J Leestma; J R Moskal
Journal:  Cancer Lett       Date:  2000-08-11       Impact factor: 8.679

6.  Poly(ADP-ribose) binds to specific domains in DNA damage checkpoint proteins.

Authors:  J M Pleschke; H E Kleczkowska; M Strohm; F R Althaus
Journal:  J Biol Chem       Date:  2000-12-29       Impact factor: 5.157

7.  Identification and characterization of genes associated with human hepatocellular carcinogenesis.

Authors:  N Kondoh; T Wakatsuki; A Ryo; A Hada; T Aihara; S Horiuchi; N Goseki; O Matsubara; K Takenaka; M Shichita; K Tanaka; M Shuda; M Yamamoto
Journal:  Cancer Res       Date:  1999-10-01       Impact factor: 12.701

8.  Caspase-dependent apoptosis induction by targeted expression of DEK in Drosophila involves histone acetylation inhibition.

Authors:  Kyu-Sun Lee; Dong-Wook Kim; Ji-Young Kim; Jong-Kil Choo; Kweon Yu; Sang-Beom Seo
Journal:  J Cell Biochem       Date:  2008-03-01       Impact factor: 4.429

9.  The acute myeloid leukemia-associated protein, DEK, forms a splicing-dependent interaction with exon-product complexes.

Authors:  T McGarvey; E Rosonina; S McCracken; Q Li; R Arnaout; E Mientjes; J A Nickerson; D Awrey; J Greenblatt; G Grosveld; B J Blencowe
Journal:  J Cell Biol       Date:  2000-07-24       Impact factor: 10.539

10.  Differential effects of the poly (ADP-ribose) polymerase (PARP) inhibitor NU1025 on topoisomerase I and II inhibitor cytotoxicity in L1210 cells in vitro.

Authors:  K J Bowman; D R Newell; A H Calvert; N J Curtin
Journal:  Br J Cancer       Date:  2001-01-05       Impact factor: 7.640

View more
  52 in total

1.  C/EBPα and DEK coordinately regulate myeloid differentiation.

Authors:  Rositsa I Koleva; Scott B Ficarro; Hanna S Radomska; Marlene J Carrasco-Alfonso; John A Alberta; James T Webber; C John Luckey; Guido Marcucci; Daniel G Tenen; Jarrod A Marto
Journal:  Blood       Date:  2012-04-03       Impact factor: 22.113

Review 2.  Control of tumorigenesis and chemoresistance by the DEK oncogene.

Authors:  Erica Riveiro-Falkenbach; María S Soengas
Journal:  Clin Cancer Res       Date:  2010-05-25       Impact factor: 12.531

3.  DEK in the synovium of patients with juvenile idiopathic arthritis: characterization of DEK antibodies and posttranslational modification of the DEK autoantigen.

Authors:  Nirit Mor-Vaknin; Ferdinand Kappes; Amalie E Dick; Maureen Legendre; Catalina Damoc; Seagal Teitz-Tennenbaum; Roland Kwok; Elisa Ferrando-May; Barbara S Adams; David M Markovitz
Journal:  Arthritis Rheum       Date:  2011-02

4.  Secreted nuclear protein DEK regulates hematopoiesis through CXCR2 signaling.

Authors:  Maegan L Capitano; Nirit Mor-Vaknin; Anjan K Saha; Scott Cooper; Maureen Legendre; Haihong Guo; Rafael Contreras-Galindo; Ferdinand Kappes; Maureen A Sartor; Christopher T Lee; Xinxin Huang; David M Markovitz; Hal E Broxmeyer
Journal:  J Clin Invest       Date:  2019-05-20       Impact factor: 14.808

Review 5.  The DEK oncoprotein and its emerging roles in gene regulation.

Authors:  C Sandén; U Gullberg
Journal:  Leukemia       Date:  2015-03-13       Impact factor: 11.528

6.  All hands on DEK.

Authors:  David M Bodine
Journal:  J Clin Invest       Date:  2019-05-20       Impact factor: 14.808

Review 7.  Stacking the DEK: from chromatin topology to cancer stem cells.

Authors:  Lisa M Privette Vinnedge; Ferdinand Kappes; Nicolas Nassar; Susanne I Wells
Journal:  Cell Cycle       Date:  2012-12-19       Impact factor: 4.534

Review 8.  Emerging metrology for high-throughput nanomaterial genotoxicology.

Authors:  Bryant C Nelson; Christa W Wright; Yuko Ibuki; Maria Moreno-Villanueva; Hanna L Karlsson; Giel Hendriks; Christopher M Sims; Neenu Singh; Shareen H Doak
Journal:  Mutagenesis       Date:  2016-08-26       Impact factor: 3.000

9.  Proteome-wide identification of poly(ADP-ribose) binding proteins and poly(ADP-ribose)-associated protein complexes.

Authors:  Jean-Philippe Gagné; Maxim Isabelle; Ken Sin Lo; Sylvie Bourassa; Michael J Hendzel; Valina L Dawson; Ted M Dawson; Guy G Poirier
Journal:  Nucleic Acids Res       Date:  2008-11-03       Impact factor: 16.971

Review 10.  Potential biological role of poly (ADP-ribose) polymerase (PARP) in male gametes.

Authors:  Ashok Agarwal; Reda Z Mahfouz; Rakesh K Sharma; Oli Sarkar; Devna Mangrola; Premendu P Mathur
Journal:  Reprod Biol Endocrinol       Date:  2009-12-05       Impact factor: 5.211

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.